Epilepsy Clinical Trials in Los Angeles

Showing 21-40 of 49 trials

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

NCT03865732

A clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in female children and young adults with genetically confirmed PCDH19 gene mutation.

PCDH19-Related Epilepsy

Marinus Pharmaceuticals29 participantsStarted May 2019

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +9 more locations

COMPLETEDPHASE2< 1 mile

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

NCT00465517

The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs). The study will also evaluate the effectiveness of ganaxolone in females with catamenial epilepsy. Catamenial epilepsy refers to a relationship between seizure frequency and a woman's menstrual cycle, where the number of seizures increases around the time of a woman's menstrual cycle.

Partial EpilepsyCatamenial Epilepsy

Marinus Pharmaceuticals147 participantsStarted Feb 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +24 more locations

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Epilepsy Trials in Other Cities

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Does Use of Rapid Response EEG Impact Clinical Decision Making

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

Eslicarbazepine Acetate Monotherapy Long Term Study

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Other Conditions in Los Angeles